Evidence map›Paper›PMID 41376987›Full record

ArticleJournal of thoracic disease2025

Evaluation of Progel in minimally invasive segmentectomy: a multicentric retrospective series.

Giulia Fabbri, Nabih Berjaoui, Akshay Patel, Alessandro Maraschi, Savvas Lampridis, Ilies Bouabdallah, Andrea Bille

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Giulia FabbriThoracic Surgery Department, Guy's Hospital, Guy's and St Thomas NHS Foundation Trust, London, UK.ORCID https://orcid.org/0000-0003-2450-103X
Nabih BerjaouiThoracic Surgery Department, Guy's Hospital, Guy's and St Thomas NHS Foundation Trust, London, UK.
Akshay PatelThoracic Surgery Department, Guy's Hospital, Guy's and St Thomas NHS Foundation Trust, London, UK.
Alessandro MaraschiThoracic Surgery Department, University College London Hospitals NHS Foundation Trust, London, UK.
Savvas LampridisThoracic Surgery Department, Guy's Hospital, Guy's and St Thomas NHS Foundation Trust, London, UK.
Ilies BouabdallahThoracic Surgery Department, Hôpital Saint Joseph, Marseille, France.
Andrea BilleThoracic Surgery Department, Guy's Hospital, Guy's and St Thomas NHS Foundation Trust, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In the past years, segmentectomy has been increasingly used to remove small peripheral lung cancers; however, segmentectomies seem to be associated with an increased incidence of prolonged air-leaks compared to lobectomies. Over the years, numerous air sealants were tested, but the most effective of all appears to be Progel Methods: Retrospective comparative cohort study of consecutive patients undergone anatomical segmentectomy at two high-volume centres between January 2018 and September 2022. Patients were divided in two groups according to whether the sealant was used. The sealant was applied intraoperatively to the remaining lung. Prolonged air leak (PAL) was defined as lasting more than 5 days. Results: One hundred and eighty-one patients were included in the study: 90 patients in the sealant group (SG) and 91 in the control group (CG). PAL was observed in 5.5% (n=5) of patients in the SG compared to 12.1% (n=11) in the CG (P=0.19). In the CG, there was a significant difference in the rate of PAL following a simple and complex segmentectomy (2.8% Conclusions: The sealant was safe and effective for intraoperative closure of air leaks following segmentectomy. Use of the sealant decreased the rate of PALs and it led to a significant reduction in chest tube duration and length of hospitalization.

Indexed as

air leaksAir sealantProgelrobotic surgerysegmentectomy

Identifiers

PMID41376987
PMCPMC12688531

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.